Navigation Links
Animals can give us a second chance at life

ave been exposed to pig cells and tissues do have pig DNA circulating in their blood,” says Fano, “And that means they most certainly have pig viruses in their blood as well.” It’s these viruses that concern her most. “We’re talking about putting the entire population at risk from a pig virus that could mutate and spread and kill lots of other people.” Biotech companies are working to eliminate that. They’re breeding pigs they say do not pass on the PERV virus --the one deemed most dangerous to humans.

While it may be too early for species to share organs, researchers continue their work -- hoping to give patients a second chance at life.

However lack of funding remains the main reason the research is going so slowly.

Researchers also say cloned pigs may play an important role in xenotransplantation and this is even mre controversial.


'"/>




Page: 1 2

Related medicine news :

1. Animals Can give us a second chance at life
2. Kidneys Can Be Transplanted From Animals Such As Pigs In Future
3. Diseases in Marine Animals Could Portend Unhealthy Prognosis for Humans
4. Regulators Object Drug Produced from Genetically Engineered Farm Animals
5. Japanese-Indonesian Joint Venture To Produce Bird Flu Vaccine For Farm Animals
6. Species Linking Fish And Land Animals Found
7. Antibiotics Used In Food Animals Causes Antibiotic Resistance In People
8. Long Term Exposure to Lab Animals Increases Immunity against Asthma
9. Vaccine Made from Live bird flu virus vaccine Offers Protection to Animals
10. Grant Encourages Drug Testing Sans Animals
11. HIV/AIDS Vaccine Tests on Animals shows Promise
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Animals can give second chance life

(Date:1/7/2009)...with hypoxia remains unclear , , WEDNESDAY...most elevated natural laboratory, Mount Everest, B... medical rules about the amount of oxygen needed b...le can tolerate extremely low levels of oxygen, mu...Grocott, from University College London and lead a...
(Date:1/7/2009)...ation,(NYSE: SYK ) announced today that it will ..., , January 14, 2009 -- 10:00 a.m. Paci...hcare Conference, San Francisco, Califo...s presentation will be available on,Stryker,s webs...e. The,presentation for the J.P. Morgan Health Ca...
(Date:1/7/2009)...tly awarded two core faculty members of the Johns ... will allow Drs. Gail Geller and Cynda Hylton Rush...ssionals face while caring for children and famili...ases (LTNMD). , The concept for this latest LTNMD...eartSongs Project funded by the Stavros Niarchos F...
(Date:1/7/2009)...tory Plans for Cutting-Edge Technology at National... , WASHINGTON, Jan. 7 Nanotechnology was incorpor...ods last year. By 2014, the market will grow to $2...bled drugs and therapeutics will be sold--up from ... project that nanotechnology will be incorporated ...
Breaking Medicine News(10 mins):Health News:Study of Everest Climbers Questions Oxygen Use 2Health News:Study of Everest Climbers Questions Oxygen Use 3Health News:Stryker To Present at Investor Conference 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 3Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 2Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 3Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 4
...p in their mother’s womb can be an indication of h...c ovarian syndrome. Polycystic ovarian syndrome is...n the childbearing age. This condition is characte...called androgens, with irregular or no menstrual c...
... Archives of Diseases in Childhood has shown that ...behavioural problems at age 14. Obesity starts fro...t can increase risk of diabetes and cardiovascular...ions of body size with psychological distress hav...
...led that the way a baby girl develops in a womb ma...tic ovarian syndrome (PCO) as adults. Dr Michael D... Reproductive Health at the University of Adelaide... team studied a group of young women bon between 1...
... that the incidence of leukemia and infections in ...ls. Stem cells are undifferentiated cells that ha...into all types of specialized cells types that may...s of the tissue from which it was taken. Researche...
Other Medicine News:Health News:Developmental Origins of Polycystic Ovarian Syndrome 2
(Date:1/5/2009)... BETHESDA, Md., Jan. 5 /PRNewswire-FirstCall/ -...utical company developing novel, proprietary,anti...nd autoimmune diseases,provides an outlook on ke... Micromet intends to provide an update on its rese...ents: , -- April 12 to 16, 2009: Update on ...
(Date:12/29/2008)...BETHESDA, Md., Dec. 29 ...an Research Protection was announced today by Dr. ... Health Improvement Institute. , , The winner ... M.D. Anderson Cancer Center -- for its best pr...This program provides for 1) enhanced human subjec...
(Date:12/17/2008)...ificant milestone met in development and validatio... ASHLAND, Mass., Dec. 17 MatTek C...ic Advisory Committee (ESAC) endorsed the scientif...n Test (SIT) at its November meeting. ESAC conclu...ccuracy and reliability for the prediction of skin...
(Date:12/17/2008)...FRANCISCO, Dec. 17 Mediv...t it has completed patient enrollment in a,Phase ... novel androgen,receptor antagonist, in castratio... will seek approval from the U.S. Food and Drug Ad... trials next year. , The open-label, U.S. P...
Breaking Medicine Technology:Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 52008 Human Research Protection Award Recipients Announced 2EpiDerm's Skin Irritation Test Fully Validated in European Union 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4At risk for peripheral arterial disease 3F Simple quiz provides key so you can circulate better 4708 1At risk for peripheral arterial disease 3F Simple quiz provides key so you can circulate better 4708 2At risk for peripheral arterial disease 3F Simple quiz provides key so you can circulate better 4708 3Air Quality Action Day Forecast Thursday in All Regions 26056 1Air Quality Action Day Forecast Thursday in All Regions 26056 2New nano device detects immune system cell signaling 26053 1New nano device detects immune system cell signaling 26053 2New nano device detects immune system cell signaling 26053 3New nano device detects immune system cell signaling 26053 4New nano device detects immune system cell signaling 26053 5Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 1Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 2Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 3Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 4Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 5Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 6
...lished today in the Journal of the National Cancer...d, 2 May 2007 - In a study published today in,the ...vative cancer,drug MabThera was shown to improve o...ss of the chemotherapy regimen used.1 The,review f... seen for,the first time in patients with mantle c...
... May 1, 2007—The drug levosimendan did not i...art failure when,compared with a more widely-used ...g to a study in the May 2 issue of, JAMA . , Acute...ailure,characterized by inability of the heart to ...mon cause of hospitalization worldwide,but approp...
Other Medicine Technology:MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 2MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 3MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 4Drug for Treatment of Heart Failure Does Not Improve Survival,Compared to More Widely-used Medication 2
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: